BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8246488)

  • 1. Kupffer cells can present alloantigen in vitro: an effect abrogated by gadolinium.
    Squiers EC; Brunson ME; Salomon DR
    J Surg Res; 1993 Dec; 55(6):571-4. PubMed ID: 8246488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis.
    Roland CR; Mangino MJ; Flye MW
    J Surg Res; 1993 May; 54(5):401-10. PubMed ID: 8361165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Kupffer cells in tolerance induction after portal venous administration of alloantigen.
    Shimizu H; Kataoka M; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Miyazaki M
    Hepatogastroenterology; 2009; 56(91-92):783-7. PubMed ID: 19621702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium.
    Roland CR; Mangino MJ; Duffy BF; Flye MW
    Transplantation; 1993 May; 55(5):1151-8. PubMed ID: 8388586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma.
    Roland CR; Walp L; Stack RM; Flye MW
    J Immunol; 1994 Dec; 153(12):5453-64. PubMed ID: 7527442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Kupffer cells in the induction of tolerance after liver transplantation.
    Sato K; Yabuki K; Haba T; Maekawa T
    J Surg Res; 1996 Jul; 63(2):433-8. PubMed ID: 8661238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation.
    Kamei T; Callery MP; Flye MW
    J Surg Res; 1990 May; 48(5):393-6. PubMed ID: 2352416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kupffer cell-mediated lymphocyte apoptosis: a PGE2-dependent mechanism of portal venous transfusion-induced immunosuppression?
    Perez R; Johnson J; Winkler JD; Rudich S; Carter L; Katznelson S; German JB
    J Surg Res; 1998 Jul; 78(1):37-41. PubMed ID: 9733615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium blocks rat Kupffer cell calcium channels: relevance to calcium-dependent prostaglandin E2 synthesis and septic mortality.
    Roland CR; Naziruddin B; Mohanakumar T; Flye MW
    Hepatology; 1999 Mar; 29(3):756-65. PubMed ID: 10051477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells--a basis of portal venous tolerance.
    Callery MP; Mangino MJ; Flye MW
    Transplantation; 1991 May; 51(5):1076-80. PubMed ID: 1827688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    J Surg Res; 2002 May; 104(1):29-35. PubMed ID: 11971674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
    Yu S; Nakafusa Y; Flye MW
    Transplantation; 1997 Dec; 64(12):1684-8. PubMed ID: 9422402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic influence on pulmonary neutrophil sequestration following intestinal ischemia-reperfusion.
    Tullis MJ; Brown S; Gewertz BL
    J Surg Res; 1996 Dec; 66(2):143-6. PubMed ID: 9024826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA; Kataoka M; Flye WM
    J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
    Asakura H; Takayashiki T; Ku G; Flye MW
    Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gadolinium-induced kupffer cell blockade on portal venous tolerance in rat skin allograft transplantation.
    Diaz-Peromingo JA; Gonzalez-Quintela A
    Eur Surg Res; 2005; 37(1):45-9. PubMed ID: 15818041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
    Takayashiki T; Asakura H; Ku G; Kataoka M; Flye MW
    Surgery; 2005 Aug; 138(2):254-60. PubMed ID: 16153434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.